INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Statistics

Total Valuation

INBIOGEN has a market cap or net worth of KRW 124.31 billion. The enterprise value is 122.36 billion.

Market Cap	124.31B
Enterprise Value	122.36B

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

INBIOGEN has 9.98 million shares outstanding.

Current Share Class	9.98M
Shares Outstanding	9.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	n/a
Float	2.06M

Valuation Ratios

The trailing PE ratio is 8.27.

PE Ratio	8.27
Forward PE	n/a
PS Ratio	16.07
PB Ratio	0.76
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.15, with an EV/FCF ratio of -46.67.

EV / Earnings	8.14
EV / Sales	15.81
EV / EBITDA	8.15
EV / EBIT	8.56
EV / FCF	-46.67

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.00.

Current Ratio	4.08
Quick Ratio	4.04
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.30
Interest Coverage	-88.56

Financial Efficiency

Return on equity (ROE) is 9.48% and return on invested capital (ROIC) is -2.27%.

Return on Equity (ROE)	9.48%
Return on Assets (ROA)	-2.24%
Return on Invested Capital (ROIC)	-2.27%
Return on Capital Employed (ROCE)	-3.54%
Revenue Per Employee	188.72M
Profits Per Employee	366.57M
Employee Count	41
Asset Turnover	0.05
Inventory Turnover	16.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.07
52-Week Price Change	n/a
50-Day Moving Average	10,965.60
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.95
Average Volume (20 Days)	51,648

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, INBIOGEN had revenue of KRW 7.74 billion and earned 15.03 billion in profits.

Revenue	7.74B
Gross Profit	-196.11M
Operating Income	-5.77B
Pretax Income	15.03B
Net Income	15.03B
EBITDA	-5.05B
EBIT	-5.77B
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 2.74 billion in cash and 783.82 million in debt, giving a net cash position of 1.96 billion or 195.82 per share.

Cash & Cash Equivalents	2.74B
Total Debt	783.82M
Net Cash	1.96B
Net Cash Per Share	195.82
Equity (Book Value)	162.56B
Book Value Per Share	n/a
Working Capital	5.07B

Cash Flow

In the last 12 months, operating cash flow was -2.52 billion and capital expenditures -98.40 million, giving a free cash flow of -2.62 billion.

Operating Cash Flow	-2.52B
Capital Expenditures	-98.40M
Free Cash Flow	-2.62B
FCF Per Share	-262.58

Margins

Gross margin is -2.53%, with operating and profit margins of -74.57% and 194.24%.

Gross Margin	-2.53%
Operating Margin	-74.57%
Pretax Margin	194.24%
Profit Margin	194.24%
EBITDA Margin	-65.29%
EBIT Margin	-74.57%
FCF Margin	n/a

Dividends & Yields

INBIOGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	12.09%
FCF Yield	-2.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 21, 2023. It was a reverse split with a ratio of 0.05.

Last Split Date	Sep 21, 2023
Split Type	Reverse
Split Ratio	0.05

Scores

INBIOGEN has an Altman Z-Score of 23.14 and a Piotroski F-Score of 2.

Altman Z-Score	23.14
Piotroski F-Score	2